Feasibility of brain tumor delineation using immunolabeled gold nanorods
Journal articles
Seekell, K; Lewis, S; Wilson, C; Grant, G; Wax, A
Published in: Optical Molecular Probes Imaging and Drug Delivery Omp 2013
January 1, 2013
The enhanced scattering of gold nanorods in the near-infrared regime provides excellent contrast for imaging within biological tissues. This study demonstrates the capability of anti-EGFR nanorods to distinguish xenograft glioblastomas from healthy murine brain tissue. ©2013 The Optical Society (OSA).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Optical Molecular Probes Imaging and Drug Delivery Omp 2013
DOI
Publication Date
January 1, 2013
Start / End Page
MW1C.3
Citation
APA
Chicago
ICMJE
MLA
NLM
Seekell, K., Lewis, S., Wilson, C., Grant, G., & Wax, A. (2013). Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013, MW1C.3. https://doi.org/10.1364/omp.2013.mw1c.3
Seekell, K., S. Lewis, C. Wilson, G. Grant, and A. Wax. “Feasibility of brain tumor delineation using immunolabeled gold nanorods.” Optical Molecular Probes Imaging and Drug Delivery Omp 2013, January 1, 2013, MW1C.3. https://doi.org/10.1364/omp.2013.mw1c.3.
Seekell K, Lewis S, Wilson C, Grant G, Wax A. Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013. 2013 Jan 1;MW1C.3.
Seekell, K., et al. “Feasibility of brain tumor delineation using immunolabeled gold nanorods.” Optical Molecular Probes Imaging and Drug Delivery Omp 2013, Jan. 2013, p. MW1C.3. Scopus, doi:10.1364/omp.2013.mw1c.3.
Seekell K, Lewis S, Wilson C, Grant G, Wax A. Feasibility of brain tumor delineation using immunolabeled gold nanorods. Optical Molecular Probes Imaging and Drug Delivery Omp 2013. 2013 Jan 1;MW1C.3.
Published In
Optical Molecular Probes Imaging and Drug Delivery Omp 2013
DOI
Publication Date
January 1, 2013
Start / End Page
MW1C.3